Protagonist Therapeutics grants inducement equity awards for 18,700 shares at $112.46 strike

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

PTGX

0.00
  • Protagonist Therapeutics granted inducement equity awards on June 15, 2026 to three newly hired employees.
  • Awards total stock options for 14,800 shares, priced at $112.46, plus 3,900 restricted stock units.
  • Options vest over four years: 25% after one year, then monthly over the next three years; RSUs vest 25% annually.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606161600ACCESSWRNAPR_____1178265) on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.